Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma.

Pharmaceutics · 2019 · PMC6523131 · PMID 30987266

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

At one μg/mL, DS showed an inhibition of 44.13 ± 0.152% at 24 h, which was quite significant, but inhibition drastically decreased to only 7.43 ± 0.057% and 4.3 ± 0.1% at 48 h and 72 h respectively.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.